Science Outreach-YINFENG LIFE EXTENSION PROGRAM

EN丨CN

Good News! Three Organoid Cryopreservation Technologies of Our Team Accepted for National Patents

The World's First In - Vitro Dual Activation Technology for Primitive Follicles: A Baby Born after Intra - operative Ovarian Tissue Freeze - Thaw Transplantation

Significant Achievements: Successfully Cultivated Human Heart in Pigs, Bringing New Hope for Organ Transplantation

Integration of Technology and Compassion: 3D Bioprinting Helps a 4-Year-Old Tibetan Girl Regain a "New Nose"

Asia's First: China Achieves Pig Kidney Transplant in Humans, Making Her the Only Person in Asia with a Pig Kidney

Bountiful Harvest: A Review of Life Extension Plan Scientific Achievements

Good News! Three Organoid Cryopreservation Technologies of Our Team Accepted for National Patents

2025/08/15

In the era of rapid development of organoid research, achieving long - term stable preservation while maintaining biological activity and functional integrity remains a crucial bottleneck restricting the clinical translation of this technology and its application in drug R & D. Recently, three technological inventions by the research team of Yinfeng Low - Temperature Medical Research Center were accepted by the National Intellectual Property Administration. These three technologies focus on the challenges of organoid cryopreservation and cover the key steps in the entire process of organoid vitrification preservation, offering a more efficient and reliable solution for safeguarding biological samples in organoid research.

The World's First In - Vitro Dual Activation Technology for Primitive Follicles: A Baby Born after Intra - operative Ovarian Tissue Freeze - Thaw Transplantation

2025/07/03

On June 25, 2025, the team led by Professor Wang Huiying and Dr. Jin Bo from Shenzhen Hospital of Beijing University of Chinese Medicine collaborated with Shandong Yinfeng Life Science Research Institute to develop the "ovarian dual activation" technology. Through this technology, patients with POI (primary ovarian insufficiency) underwent intra - operative freeze - thaw activation of ovarian tissue. After intra - operative transplantation, a baby was born, and both the mother and the baby are healthy and safe.

Significant Achievements: Successfully Cultivated Human Heart in Pigs, Bringing New Hope for Organ Transplantation

2025/06/19

Recently, the world's top - tier academic journal Nature featured a major research achievement by Chinese scientists on its front - page headlines. For the first time, a heart containing human cells was cultivated in a pig embryo, and this heart could beat autonomously and survived for 21 days. This groundbreaking progress offers a brand - new solution to the global shortage of organ transplants and marks a new stage in the development of xenogeneic organ cultivation technology.

Integration of Technology and Compassion: 3D Bioprinting Helps a 4-Year-Old Tibetan Girl Regain a "New Nose"

2025/03/21

Asia's First: China Achieves Pig Kidney Transplant in Humans, Making Her the Only Person in Asia with a Pig Kidney

2025/03/13

Bountiful Harvest: A Review of Life Extension Plan Scientific Achievements

2025/02/07

With the rapid development of science and technology, humanity's exploration of life has never ceased. During the 2023-2024 period, we witnessed a series of exciting scientific achievements. These not only made significant progress in fields such as anti-aging, gene editing, organ regeneration, and immunotherapy but also pointed the way for future medical research.

2017-03-16

→

Human tissue and organ cryopreservation technology

At normal temperature, isolated ischemic tissues and organs will die within a short period of time (from a few minutes to a few hours at most) and cannot be used for transplantation. It is impossible to complete the transplant operation in such a short period of time. Therefore, tissue and organ cryopreservation technology is needed to maintain their activity.

2017-03-13

→

Cryoprotectant

Cryoprotectants are the basis for research on cryopreservation of various human cells, tissues, and organs. Since the discovery of the cryoprotective effect of glycerol in the 1960s, more than 50 drugs or reagents have been used for cryoprotection. In recent years, with the development of vitrification technology, in-depth research on cryoprotectants has attracted the attention of many researchers.

2017-03-13

→

Cryogenic equipment

The relationship between the energy difference input to the sample under test and the reference substance and temperature (or time) can be measured through programmable temperature control. The application range is very wide, especially in the research and development, performance testing and quality control of materials, such as glass transition temperature, cold crystallization, phase transition, melting, crystallization, product stability, solidification/cross-linking, oxidation induction period and other research fields.